| type |
title |
author |
url |
date |
domain |
secondary_domains |
format |
status |
priority |
tags |
processed_by |
processed_date |
enrichments_applied |
extraction_model |
| source |
CMS 2027 Medicare Advantage and Part D Advance Notice: Chart Review Exclusion and Star Ratings Reform |
CMS / Multiple analysis sources |
https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-advance-notice |
2026-02-01 |
health |
|
report |
enrichment |
high |
| cms |
| medicare-advantage |
| 2027-rates |
| chart-review-exclusion |
| star-ratings |
| V28 |
| risk-adjustment |
|
vida |
2026-03-16 |
| CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md |
| Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md |
| medicare-fiscal-pressure-forces-ma-reform-by-2030s-through-arithmetic-not-ideology.md |
|
anthropic/claude-sonnet-4.5 |
Content
Chart Review Exclusion (2027)
- CMS proposes excluding ALL diagnoses from unlinked chart review records (not tied to documented service)
- Diagnoses from chart reviews allowed only if tied to actual medical encounter
- Projected savings: >$7 billion in 2027
- This is the most targeted reform to date against retrospective code-mining
V28 Phase-In Completion
- 2026 is the FINAL year of V28 phase-in
- 2027 model continues V28 clinical classification but recalibrated with newer data (2023 diagnoses, 2024 expenditures — updated from 2018/2019)
- Notable: CKD Stage 3B and 3 now have separate coefficients (previously constrained to same value)
Star Ratings Reforms
- New depression screening and follow-up measure (2027 measurement year, 2029 ratings)
- CMS exploring modernization: AI-based risk adjustment, alternative data sources
- Exploring timeline compression to reduce current 2-year lag between measurement and payment
Industry Impact
- Insurers warn flat 2027 rates + chart review exclusion could drive benefit cuts and market exits
- Combined with V28 completion, this is the most structurally significant reform year since MMA 2003
- Purpose-built MA plans (lower coding intensity, genuine care delivery) are better positioned than acquisition-based plans
Forward-Looking Signals
- CMS exploring next-generation AI-powered risk adjustment model
- Potential for quality measurement timeline modernization
- Signals continued regulatory tightening trajectory
Agent Notes
Why this matters: 2027 is shaping up as a structural inflection for MA. Chart review exclusion + V28 completion + flat rates = the first sustained compression of MA economics since the BBA 1997 crash. The key question: does this trigger another 1997-style plan exit cycle, or have purpose-built plans evolved enough to survive where acquisition-based models fail?
What surprised me: CMS is exploring AI-powered risk adjustment. If implemented, this would fundamentally change the coding game — AI could detect upcoding patterns across millions of records in ways that audit sampling can't.
KB connections: CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring, Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening
Extraction hints: Claim about 2027 as structural inflection year for MA economics — convergence of V28, chart review exclusion, and flat rates creating the first sustained compression since BBA 1997.
Curator Notes
PRIMARY CONNECTION: CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring
WHY ARCHIVED: Updates and deepens the existing KB claim with the full 2027 reform package context.
EXTRACTION HINT: The parallel to BBA 1997 is the key analytical frame — will 2027 trigger plan exits or differentiation?
Key Facts
- CMS 2027 chart review exclusion projects >$7 billion in savings
- 2026 is the final year of V28 phase-in
- 2027 V28 recalibration uses 2023 diagnoses and 2024 expenditures
- CKD Stage 3B and 3 now have separate coefficients in V28 (previously constrained)
- New depression screening and follow-up measure for 2027 measurement year, 2029 ratings
- CMS exploring AI-based risk adjustment and alternative data sources for Star Ratings
- CMS exploring timeline compression to reduce 2-year lag between measurement and payment
